ETM* Is Indispensable to Endothelial Cell Physiology during Pathological Angiogenesis
ISEF · 2019 Cellular and Molecular Biology
Overview
Angiogenesis is requisite for the growth and metastatic spread of solid tumors. Identifying pathological angiogenesis regulators will provide therapeutic targets against solid tumor growth. This study’s aims were 1) to identify the role Etv2 Target M* (ETM*) in endothelial cell (EC) physiology during angiogenesis, and 2) to assess ETM's* potential as a therapeutic target against tumor angiogenesis in vitro. Analysis of NCBI GEO microarray data revealed ETM* dysregulation during breast (p<0.0001), colon (p<0.001), and renal cancer (p<0.01), suggesting ETM* may regulate tumor angiogenesis. Hallmark angiogenic endothelial functions—proliferation, migration, sprout formation, and tube formation—were quantified in ETM* knockdown (KD) ECs. Boyden chamber and proliferation assays in ETM* KD ECs revealed a 3-fold decrease in migration (p<0.0001) and 20% decrease in proliferation rate (p<0.0001). Wild-type ECs formed 4 times the number of angiogenic sprouts with a 2:1 length ratio compared to ETM* KD ECs (p<0.0001). Additionally, ETM* KD ECs were incapable of forming vascular networks in vitro. Deficient migration, proliferation, sprout formation, and tube formation in ETM* KD ECs highlights ETM's* role during angiogenesis. Remarkably, tumor spheroids co-cultured with ECs as an in vitro model for tumor angiogenesis showed ETM* KD ECs could not form vasculature towards tumors unlike wild-type ECs. ETM* is, therefore, indispensable to endothelial physiology during tumor angiogenesis. Future investigations are required to identify a safe and efficient delivery mechanism for ETM* siRNA as an anti-angiogenic therapy which may curtail the life-threatening effects of solid tumors.
Awards (3)
- First Award of $3,000 $3,000
- National Anti-Vivisection Society: Third Award of $2,500 $2,500
- Serving Society Through Science: First Award of $1000 $1,000
Competition history
- ISEF 2019
Resources
Related projects
ISEF · 2020
Expression of c-MYC in Human Endothelial Cells Results in Abnormal Vascular Morphogenesis and Metabolic Reprogramming
ISEF · 2017
Identification of TBX3 as a Novel Regulator of Lung Angiogenesis
ISEF · 2018
Examining the Effect of HIF and Notch in Endothelial Cell Migration and Sprouting
ISEF · 2017
Understanding the Proteins Involved in Regenerative Angiogenesis
ISEF · 2026
Identification of a Novel TBX2-Dependent Mechanism Linking Pericyte Dynamics to Abnormal Vasculature in Lung Adenocarcinoma
ISEF · 2021
Assessing the Expression of Angiogenesis-Related Receptors in Endothelial Cell RNA
ISEF · 2023
TNF Ligand Promotes Angiogenesis in Triple Negative Breast Cancer Through Activation of Inflammatory Regulatory Networks
ISEF · 2025
Investigating the Synergistic Role of IL-1BETA and TGF-BETA in Endothelial-to- Mesenchymal Transition in Coronary Artery Disease
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair